Prophylaxis of menstrual migraine with triptans: Problems and possibilities

Neurology

Volumn 59, Issue 11, 2002, Pages 1677-1681

  Loder, Elizabeth ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; TRIPTAN; UNCLASSIFIED DRUG;

COST; DISEASE ASSOCIATION; DRUG SAFETY; HUMAN; MENSTRUATION DISORDER; MIGRAINE; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RELIABILITY; REVIEW; SAFETY; TREATMENT INDICATION; VALIDATION PROCESS;

EID: 0037058764     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000034179.17926.2D     Document Type: Review

References (42)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine in the United States: Relation to age, income, race and other sociodemographic factors. JAMA 1992;287:64-69.
2. Silberstein SD. Menstrual migraine. J Womens Health Gend Based Med 1999;8:919-931.
3. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: A double-blind, placebo controlled study. Headache 1990;30:705-709.
4. Magos AL, Zilkha KJ, Studd JWW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 1983;46:1044-1046.
5. DeLignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986;293:1540.
6. D'Alessandro R, Gamberini G, Lozito A, Sacquegna T. Menstrual migraine: Intermittent prophylaxis with a timed-release formulation of dihydroergotamine. Cephalalgia 1983; 15:158.
7. Facchinetti F, Montorsi S, Borella P, et al. Magnesium prevention of premenstrual migraine: A placebo controlled study. In: Rose FC, ed. New Advances in Headache Research, 2nd Ed. London: Smith-Gordon, 1991.
8. O'Dea PK, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology 1990;40:1470-1471.
9. Powles TJ. Prevention of migrainous headaches by tamoxifen. Lancet 1986;2:1344.
10. Herzog AG. Continuous bromocriptine therapy in menstrual migraine. Neurology 1997;48:101-102.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 suppl 7:1-96.
12. MacGregor E. "Menstrual" migraine: Towards a definition. Cephalalgia 1996;16:11-21.
13. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355-365.
14. Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology 1991;41:786-793.
15. Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache 1985;25:376-379.
16. McFarland C. Women's theories of menstruation and biases in recall of menstrual symptoms. J Pers Soc Psychol 1989;57: 522-531.
17. Waters WE, O'Connor PJ. Epidemiology of headache and migraine in women. J Neurol Neurosurg Psychiatry 1971;34: 148-153.
18. Stewart WF, Lipton RB, Chee E, et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000;55:1517-1523.
19. Silberstein SD, Massiou H, LeJeunne C, Johnson-Pratt L, McCarroll KA, Lines CR. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000;96:237-242.
20. Loder E, Silberstein S. Clinical efficacy of 2.5 and 5 mg zolmitriptan in migraine associated with menses or in patients using non-progestogen oral contraceptives. Neurology 1998; 50(suppl 4):A341. Abstract S46.
21. Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine: A review of prospective studies and retrospective analyses. Cephalalgia 1999;19:16-19.
22. Massiou H, Pitei D, Poole PH, Sikes C. Efficacy of eletriptan for the treatment of migraine in women with menstrually associated migraine, and in women on contraceptives or hormone replacement therapy: Meta-analyses of randomized clinical trials. Poster presentation. Presented at: Headache World 2000; September 3-7, 2000; London, UK.
23. MacGregor EA, Keywood C. Frovatriptan is effective in menstrually associated migraine. Poster presentation. Presented at: Headache World 2000; September 3-7, 2000; London, UK.
24. Silberstein SD, Stewart WF, Lipton RB. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin and caffeine: Results from three randomized, placebo-controlled studies. Clin Ther 1999;21:475-491.
25. Massiou H, Silberstein S, McCarroll K, Allen C, Lines C. Further evaluation of the efficacy of rizatriptan in menstrual migraine: Freedom from pain and associated symptoms at 2 h and 24-h sustained pain free status. Abstract. Presented at: Headache World 2000; September 3-7, 2000; London, UK.
26. Eekers PJE, Koehler PJ. Naratriptan prophylactic treatment in cluster headache. Cephalalgia 2001;21:75-76.
27. Loder E. Naratriptan in the prophylaxis of cluster headache. Headache 2002;42:56-57.
28. Sheftell FD, Rapoport AM, Coddon DR. Naratriptan in the prophylaxis of transformed migraine. Headache 1999;39:506-510.
29. Ferrari MD, James MH, Bates D, et al. Oral sumatriptan: Effect of a second dose, and incidence and treatment of headache recurrence. Cephalalgia 1994;14:330-338.
30. Monstad I, Krabbe A, Micieli G, et al. Oral treatment with sumatriptan during a cluster period. Headache 1995;35:607-613.
31. Bates D, Ashford E, Dowson R, et al. Subcutaneous sumatriptan during the migraine aura. Neurology 1994;44: 1587-1592.
32. Weiller C, May A, Limmroth V, et al. Brainstem activation in spontaneous human migraine attacks. Nat Med 1995;7:658-660.
33. Treolar A, Bounton R, Behn B, Brown B. Variation of the human menstrual cycle through reproductive life. Int J Infertil 1967;12:77.
34. O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox AW. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia 1999;19:223-231.
35. Knudsen F, Friedman B, Chen M, Goldwasser JE. Sumatriptan use and ischemic colitis. Arch Intern Med 1998;158:1946-1948.
36. Osborne MJ, Austin RCT, Dawson KJ, Lange L. Is there a problem with long-term use of sumatriptan in acute migraine? BMJ 1994;308:113.
37. Limmroth V, Kazarawa S, Fritsche G, Diener HC. Headache after frequent use of new serotonin agonists zolmitriptan and naratriptan. Lancet 1999;353:378.
38. Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998;51:307-309.
39. Newman L. A double-blind, randomized, placebo-controlled trial of naratriptan in the prophylaxis of menstrual migraine. Headache 2001;41:248-256.
40. New "triptans" and other drugs for migraine. The Medical Letter Oct 9, 1998;1037:97-100.
41. March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P. N-of-1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994;309:1041-1046.
42. Lay CL, Newman LC. Menstrual migraine: Approaches to management. CNS Drugs 1999;12:189-195.